Superbugs Win Another Round as Big Pharma Leaves Antibiotics
James Paton and Naomi Kresge report on the fight against drug-resistant bacteria as Novartis AG announced its decision to end antibacterial and antiviral research. They quote Gabrielle Breugelmans, Director of Research at the Access to Medicine Foundation, who noted that ”Novartis pulling out makes us a little worried, because they had a relatively large pipeline.”